Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is positioned for long-term success with its strong financial position, well-established payment sources, and ongoing strategic partnerships with hospitals. Additionally, its recent expansion in industrial injury prevention, smart cost management strategies, and potential for future M&A opportunities further supports a positive outlook on the stock. With a strong track record of meeting internal expectations and high conviction in meeting its forecasted adjusted EBITDA for FY/26, US Physical Therapy remains a good investment opportunity for investors.

Bears say

US Physical Therapy is expected to experience an increase in revenue over the next two years, driven by strong growth in their physical therapy operations segment and improved margins. Recent results have beaten analyst estimates and there is potential for additional upside from new hospital system relationships. However, the company's reliance on managed care programs and insurance reimbursements may present some financial risks, and it is important to closely monitor changes in healthcare policies and regulations.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $99.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $99.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.